I. Katsumi

Specific inhibitors of tyrosine-specific protein kinase. I. Synthesis and inhibitory activities of alpha-cyanocinnamamides.

K Watanabe, K. Watanabe, T Shiraishi, 1988, Chemical & pharmaceutical bulletin.

Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by α-(3,5-di-tert-butyl-4-hydroxybenzylidene)-γ-butyrolactone (KME-4), a new anti-inflammatory drug

I. Katsumi, T. Yamashita, Kiyoshi Watanabe, 1985 .

Pharmacological Properties of a New Anti-Inflammatory Compound, α-(3,5-Di-Tert-Butyl-4-Hydroxybenzylidene)-γ-Butyrolactone (KME-4), and Its Inhibitory Effects on Prostaglandin Synthetase and 5-Lipoxygenase

I. Katsumi, T. Yamashita, Kiyoshi Watanabe, 1984 .

The effect of α‐(3,5‐di‐t‐butyl‐4‐hydroxybenzylidene)‐γ‐butyrolactone (KME‐4), a new anti‐inflammatory drug, on leucocyte migration in rat carrageenan pleurisy

I. Katsumi, T. Yamashita, Kiyoshi Watanabe, 1986 .

Studies on styrene derivatives. II. Synthesis and antiinflammatory activity of 3,5-di-tert-butyl-4-hydroxystyrenes.

I. Katsumi, T. Yamashita, K. Hosoe, 1986, Chemical & pharmaceutical bulletin.

Studies on styrene derivatives. I. Synthesis and antiinflammatory activities of alpha-benzylidene-gamma-butyrolactone derivatives.

I. Katsumi, T. Yamashita, K. Hosoe, 1986, Chemical & pharmaceutical bulletin.

Studies on Styrene Derivatives. Part 1. Synthesis and Antiinflammatory Activities of α-Benzylidene-γ-butyrolactone Derivatives.

I. Katsumi, T. Yamashita, Kiyoshi Watanabe, 1986 .

Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.

I. Katsumi, T. Yamashita, K. Hosoe, 1984, Japanese journal of pharmacology.